Insulin resistance, central obesity, and risk of colorectal adenomas

Cancer

Volumn 118, Issue 7, 2012, Pages 1774-1781

  Ortiz, Ana Patricia ^a   Thompson, Cheryl L ^b   Chak, Amitabh ^c,d   Berger, Nathan A ^c   Li, Li ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Central obesity; Colorectal adenomas; Cross sectional study; Insulin resistance

Indexed keywords

ANTIDIABETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECTUM POLYP; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEX; WAIST HIP RATIO;

ADENOMA; BLOOD GLUCOSE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; WAIST-HIP RATIO;

EID: 84858707593     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26454     Document Type: Article

References (41)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2005 Incidence and Mortality Website Report. Published 2009. Available at: http://apps.nccd.cdc.gov/uscs/ Table.aspx? Group=3f&Year=2005&Display=n Accessed November 13, 2009.
2. Komninou D, Ayonote A, Richie JP Jr, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood). 2003;228:396-405. (Pubitemid 37203647)
3. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev.1994;3:687-695. (Pubitemid 24377963)
4. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6:164-179.
5. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-591. (Pubitemid 39025053)
6. Sedjo RL, Byers T, Levin TR, et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2007;16:526-531. (Pubitemid 46548656)
7. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327-334.
8. Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res. 2005;11: 3642-3646. (Pubitemid 40685579)
9. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999;91:1147-1154. (Pubitemid 29330553)
10. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254-260. (Pubitemid 12006594)
11. Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer. 1997;29:69-76. (Pubitemid 27508127)
12. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol. 2009;15:5141-5148.
13. Flood A, Mai V, Pfeiffer R, et al. Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology. 2007;133:1423-1429. (Pubitemid 350029750)
14. Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2005;14:2076-2081. (Pubitemid 41603248)
15. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836-s842.
16. Yamamoto S, Nakagawa T, Matsushita Y, et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care. 2010;33:184-189.
17. Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol. 2010;10:51.
18. Tsilidis KK, Bracati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010;21:1-10.
19. Ashbeck EL, Jacobs ET, Martinez ME, Gerner EW, Lance P, Thompson PA. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18:1134-1143.
20. Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev. 2007;16:1543-1546.
21. Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev. 2005;6:485-489.
22. Trevisan M, Liu J, Muti P, et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001; 10:937-941. (Pubitemid 32844900)
23. Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology. 2006;147:1830-1837.
24. Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord. 2009;7:279-288.
25. Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, et al. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol. 2006;4:1514-1521. (Pubitemid 44880028)
26. Ehrmann-Josko A, Sieminska J, Gornicka B, Ziarkiewicz-Wroblewska B, Ziolkowski B, Muszynski J. Impaired glucose metabolism in colorectal cancer. Scand J Gastroenterol. 2006;41:1079-1086.
27. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010;25:205-212.
28. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenomacarcinoma sequence. Br J Surg. 2002;89:845-860.
29. Lee HL, Son BK, Lee OY, et al. Abdominal obesity, insulin resistance, and the risk of colonic adenoma. Korean J Gastroenterol. 2007;49:147-151.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
31. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495. (Pubitemid 38680001)
32. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11 suppl):3109S-3120S. (Pubitemid 33070788)
33. Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008;67:128-145. (Pubitemid 351543395)
34. International Agency for Research on Cancer. Weight Control and Physical Activity, IARC Handbook of Cancer Prevention. Vol 6. Published 2002. Available at: http://www.iarc.fr/en/publications/list/ handbooks/ Accessed November 13, 2009.
35. Foltyn W, Kos-Kudla B, Strzelczyk J, et al. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly? Neuro Endocrinol Lett.2008;29:107-112.
36. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101:48-60.
37. Rondini EA, Harvey AE, Steibel JP, Hursting SD, Fenton JI. Energy balance modulates colon tumor growth: interactive roles of insulin and estrogen. Mol Carcinog. 2011;50:370-382.
38. De Pergola G, Tartagni M, d'Angelo F, Centoducati C, Guida P, Giorgino R. Abdominal fat accumulation, and not insulin resistance, is associated to oligomenorrhea in non-hyperandrogenic overweight/obese women. J Endocrinol Invest. 2009;32:98-101.
39. Terry PD, Miller AB, Rohan TE. Obesity and colorectal cancer risk in women. Gut. 2002;51:191-194. (Pubitemid 34791445)
40. Platz EA, Martinez ME, Grodstein F, et al. Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control. 1997;8:894-903.
41. Hosono K, Endo H, Takahashi H, et al. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila). 2010;3:1077-1083.